P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates

Company Performance - P3 Health Partners Inc. reported a quarterly loss of $6.28 per share, which was worse than the Zacks Consensus Estimate of a loss of $5, and an improvement from a loss of $8 per share a year ago, indicating a surprise of -25.60% [1] - The company posted revenues of $373.23 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 2.61%, but down from $388.49 million in the same quarter last year [2] - P3 Health Partners has not surpassed consensus EPS estimates over the last four quarters, and its shares have lost about 27.3% since the beginning of the year [3][4] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$4 on revenues of $349.3 million, and for the current fiscal year, it is -$18 on revenues of $1.41 billion [7] - The estimate revisions trend for P3 Health Partners is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, suggesting it is expected to outperform the market in the near future [6] Industry Context - The Medical Info Systems industry, to which P3 Health Partners belongs, is currently in the top 20% of over 250 Zacks industries, indicating a positive outlook for stocks within this sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]